Free Trial
NASDAQ:NRXS

NeurAxis (NRXS) Stock Price, News & Analysis

NeurAxis logo
$2.65
+0.02 (+0.76%)
(As of 10/31/2024 ET)

About NeurAxis Stock (NASDAQ:NRXS)

Key Stats

Today's Range
$2.54
$2.70
50-Day Range
$2.58
$3.23
52-Week Range
$1.88
$3.89
Volume
7,818 shs
Average Volume
9,050 shs
Market Capitalization
$18.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Receive NRXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter.

NRXS Stock News Headlines

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
VBI Vaccines Inc. (VBIVQ)
See More Headlines

NRXS Stock Analysis - Frequently Asked Questions

NeurAxis' stock was trading at $2.67 at the start of the year. Since then, NRXS stock has decreased by 2.6% and is now trading at $2.60.
View the best growth stocks for 2024 here
.

NeurAxis, Inc. (NASDAQ:NRXS) issued its earnings results on Friday, August, 9th. The company reported ($0.42) earnings per share for the quarter. The firm earned $0.61 million during the quarter.

NeurAxis (NRXS) raised $7 million in an initial public offering (IPO) on Wednesday, August 9th 2023. The company issued 1,098,667 shares at $6.00 per share.

Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeurAxis investors own include AutoZone (AZO), Intel (INTC), Meta Platforms (META), AMMO (POWW), SPDR S&P 500 ETF Trust (SPY), TJX Companies (TJX) and X-Links Crude Oil Shares Covered Call ETN (USOI).

Company Calendar

Last Earnings
8/09/2024
Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NRXS
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Net Income
$-14,630,000.00
Net Margins
-672.66%
Pretax Margin
-672.71%

Debt

Sales & Book Value

Annual Sales
$2.27 million
Book Value
($0.27) per share

Miscellaneous

Free Float
5,802,000
Market Cap
$17.79 million
Optionable
Not Optionable
Beta
4.30
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:NRXS) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners